Country: GERMANY
                            Affiliation: 
                        
                                
                                WATCH
                                The introduction of anti-VEGF compounds more than a decade ago represented a paradigm shift of undisputable magnitude. Nevertheless, many unmet needs in the management of age-related macular degeneration still remain. Read more